不同中医辨证分型NAFLD患者CT影像学特点分析

doi:10.3969/j.issn.1672-5069.2021.02.017

Abstract

Abstract: Objective The aim of this study was to investigate the CT imaging feature in patients with non-alcoholic fatty liver diseases (NAFLD) with different traditional Chinese medicine (TCM) syndrome.Methods 240 patients with NAFLD were enrolled in our hospital between January 2017 and January 2020, and the TCM syndrome were determined. All patients underwent CT scan.Results The percentage of mild fatty liver by CT diagnosis in patients with liver depression and spleen deficiency was 88.9%, significantly higher than 17.6%, 25.8%, 6.5% and 0.0%(P＜0.05) in patients with damp phlegm and internal resistance syndrome, damp heat and internal gathering syndrome, phlegm and blood stasis syndrome and liver and kidney deficiency syndrome; the percentage of severe fatty liver in patients with liver and kidney deficiency syndrome was 85.7%, and that in patients with phlegm and blood stasis syndrome was 51.6%, significantly higher than 0.0% in patients with liver depression and spleen deficiency, 8.8% in with damp phlegm and internal resistance and 15.7% in damp heat and internal gathering syndrome(P＜0.05); the CT score in patients with liver depression and spleen deficiency was (42.4±4.7)HU and the CT score in patients with damp phlegm and internal resistance was(37.0±5.6)HU, both significantly higher than [(32.0±5.8)HU, (27.0±6.2)HU and (22.8±7.9)respectively, P＜0.05】 in patieHU,nts with damp heat and internal gathering, in with ph legm and blood stasis syndrome and in with liver and kidney deficiency syndrome, while the liver/spleen ratio were (0.8±0.1) and (0.7±0.2),significantly higher than【(0.6±0.1), (0.5±0.1) and (0.4±0.1), respectively, P＜0.05】 in patients with damp phlegm and internal resistance, in patients with damp heat and internal gathering and in with liver and kidney deficiency syndrome.Conclusion The CT imaging of patients with NAFLD with different TCM syndromes is characteristic, which might help the TCM doctors to deal with the entity appropriately in clinical practice.

Key words: Nonalcoholic fatty liver disease, Chinese traditional medicine, TCM syndrome, Computed tomography, Feature

Xu Leilei, Xu Guanying, Jiang Kai, et al. CT imaging feature in patients with non-alcoholic fatty liver diseases with different TCM syndrome[J]. Journal of Practical Hepatology, 2021, 24(2): 216-219.

References

[1] Younossi ZM, Marchesini G, Pinto-Cortez H, et al. Epidemiology of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: implications for liver transplantation. Transplantation, 2019, 103(1):22-27.
[2] Younossi ZM, Golabi P, de Avila L , et al. The global epidemiology of NAFLD and NASH in patients with type 2 diabetes: a systematic review and meta-analysis. J Hepatol, 2019, 71(4):793-801.
[3] Tateishi R, Koike K. Epidemiology and risk factors of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH).Nihon Shokakibyo Gakkai Zasshi, 2017, 114(5):813-818.
[4] Tomic D, Kemp WW, Roberts SK. Nonalcoholic fatty liver disease: current concepts, epidemiology and management strategies. Eur J Gastroenterol Hepatol, 2018, 30(10):1103-1115.
[5] Golabi P, Paik J, Reddy R, et al. Prevalence and long-term outcomes of non-alcoholic fatty liver disease among elderly individuals from the United States. BMC Gastroenterol, 2019, 19(1):56-62.
[6] Zhang JZ, Cai JJ, Yu Y , et al. Nonalcoholic fatty liver disease: an update on the diagnosis. Gene Expr, 2019, 19(3):187-198.
[7] 严桐, 郑婷婷, 易婷, 等. 基于文献数据挖掘的酒精性脂肪肝中医证候分布特点. 中华中医药学刊, 2019, 37(10):2503-2506.
[8] 中华医学会肝脏病学分会脂肪肝和酒精性肝病学组. 非酒精性脂肪性肝病诊疗指南. 实用肝脏病杂志, 2007, 10(1):1-3.
[9] 李志国, 姜韩雪, 焦云涛, 等. 非酒精性脂肪性肝病中医证型分布的文献分析. 中华中医药杂志, 2017, 32(10):4713-4715.
[10] Cai J, Zhang XJ, Li H . Progress and challenges in the prevention and control of nonalcoholic fatty liver disease. Med Res Rev, 2019, 39(1):328-348.
[11] Draijer L, Benninga M, Koot B. Pediatric NAFLD: an overview and recent developments in diagnostics and treatment. Expert Rev Gastroenterol Hepatol, 2019, 13(5):447-461.
[12] Qin L , Zhang W , Yang Z , et al. Impaired lung function is associated with non-alcoholic fatty liver disease independently of metabolic syndrome features in middle-aged and elderly Chinese. BMC Endocr Disord, 2017, 17(1):18-24.
[13] Kountouras J, Polyzos SA, Katsinelos P, et al. Helicobacter pylori in lean and obese patients with non-alcoholic fatty liver disease.Aliment Pharmacol Ther, 2017, 46(6):637-638.
[14] Yao H, Qiao YJ, Zhao YL , et al. Herbal medicines and nonalcoholic fatty liver disease. World J Gastroenterol, 2016, 22(30):6890-6905.
[15] 林立, 孙华胜, 毛乾国, 等. 非酒精性脂肪肝同病异证与肝活检病理学的相关性研究. 中华中医药杂志, 2019, 34(4):1462-1465.
[16] Xu ZJ, Shi JP, Yu DR, et al. Evaluating the relationship between metabolic syndrome and liver biopsy-proven non-alcoholic steatohepatitis in China: a multicenter cross-sectional study design. Adv Ther, 2016, 33(11):2069-2081.
[17] Hannah WN Jr, Harrison SA. Non-invasive imaging methods to determine severity of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. Hepatology, 2016, 64(6):2234-2243.
[18] Jia GS , Feng GL , Li JP , et al. Using receiver operating characteristic curves to evaluate the diagnostic value of the combination of multislice spiral CT and alpha-fetoprotein levels for small hepatocellular carcinoma in cirrhotic patients. Hepatobiliary Pancreat Dis Int, 2017, 16(3):303-309.
[19] 许旌, 杨立, 师璇, 等. 老年非酒精性脂肪性肝病患者100例的认知功能观察和临床特点. 中华消化杂志, 2019, 39(1):35-39.
[20] Petäjä EM, Yki-Järvinen H . Definitions of normal liver fat and the association of insulin sensitivity with acquired and genetic NAFLD-a systematic review. Int J Mol Sci, 2016, 17(5):633-648.

CT imaging feature in patients with non-alcoholic fatty liver diseases with different TCM syndrome

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	Wang Mengyu, Yang Ruixu, Fan Jiangao. Clinical feature and outcomes of patients with metabolic associated fatty liver diseases [J]. Journal of Practical Hepatology, 2021, 24(3): 308-311.
[2]	Chen Xi, Wang Wei, Gao Jianwei, et al. Impact of antiviral therapy efficacy of entecavir in patients with chronic hepatitis B and concomitant nonalcoholic fatty liver diseases [J]. Journal of Practical Hepatology, 2021, 24(3): 343-346.
[3]	Jia Qunling, Xu Zhibin, Han Shu. Implication of magnetic resonanceimaging-proton density fat fraction in patients with nonalcoholic fatty liver diseases [J]. Journal of Practical Hepatology, 2021, 24(3): 359-362.
[4]	Liu Xiangji, Liu Zhenxian, Wang Xiaoyan. Incidence of gallstone disease in middle-aged and elderly patients with nonalcoholic fatty liver disease and its relation to metabolic risk factors [J]. Journal of Practical Hepatology, 2021, 24(3): 363-366.
[5]	Jin Ying, Zhou Weizhen, Feng Shibing, et al. Prevalence of nonalcoholic fatty liver diseases in patients with intracerebral hemorrhage [J]. Journal of Practical Hepatology, 2021, 24(3): 367-370.
[6]	Liu Songtao, Meng Qinghua, Lyu Jun, et al. Clinical feature and prognosis of lymphoma patients with chemotherapy-induced liver failure [J]. Journal of Practical Hepatology, 2021, 24(3): 383-386.
[7]	Kong Xuejie, Li Jiang, Li Haotian, et al. Clinical feature and efficacy of different prognostic scoring models in patients with acute-on-chronic liver failure with different underlying liver diseases [J]. Journal of Practical Hepatology, 2021, 24(3): 387-390.
[8]	Gao Huiru, Gao Huibin, Peng Zhao, et al. Clinical feature and impacting factors of esophageal and gastric variceal bleeding in patients with hepatitis B-induced liver cirrhosis [J]. Journal of Practical Hepatology, 2021, 24(3): 395-398.
[9]	Li Hua, Wen Jianghua, Wu Yingchun, et al. Clinical features of patients with alcoholic cirrhosis [J]. Journal of Practical Hepatology, 2021, 24(3): 411-414.
[10]	Zhou Hui, Feng Xiaoning, Ren Hao, et al. Clinical features and hepatic venous pressure gradientchanges in patients with noncirrhotic portal hypertension [J]. Journal of Practical Hepatology, 2021, 24(3): 415-418.
[11]	Wang Yaozheng, Wang Yulin, Lin Yi. Diagnostic efficacy of ¹⁸F-FDG PET/CT scan in patients with ntrahepatic cholangiocarcinoma [J]. Journal of Practical Hepatology, 2021, 24(3): 427-430.
[12]	Gan Yanying, Zhong Kai, Guan Yanling, et al. Diagnostic efficacy of ultrasonography,CT and MRCP in the diagnosis of extrahepatic bile duct stones [J]. Journal of Practical Hepatology, 2021, 24(3): 439-442.
[13]	Chen Guangyu, Wang Hong, Wang Yaoshen, et al. Blood hemoglobin levels for risk of individuals apt to have nonalcoholic fatty liver disease risk [J]. Journal of Practical Hepatology, 2021, 24(1): 39-42.
[14]	Wei Xiuqin, Yan Xiaoxia, Shi Guorong, et al. Short-termefficacy of atorvastatin and tiopronin combination in the treatment of patients with nonalcoholic fatty liver diseases [J]. Journal of Practical Hepatology, 2021, 24(1): 47-50.
[15]	Liang Xiaoli,Kuang Jisun,Liu Qiuli,et al. Therapeutic efficacy of fenofibrate at base of calorie restriction diet in the treatment of patients with non-alcoholic fatty liver disease and type 2 diabetes [J]. Journal of Practical Hepatology, 2021, 24(1): 51-54.